Scarica l'app Stockscreener
2.86
1.78%
0.05
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Anixa Biosciences Inc Borsa (ANIX) Ultime notizie
Anixa Biosciences CEO Calls 2026 “Pivotal” as Breast Cancer Vaccine, Ovarian CAR-T Advance - MarketBeat
ANIX: Pivotal data from advanced cancer trials and fiscal discipline set the stage for a transformative 2026 - TradingView
Anixa reports promising survival data in ovarian cancer CAR-T trial - Investing.com Australia
Anixa reports promising survival data in ovarian cancer CAR-T trial By Investing.com - Investing.com South Africa
Anixa Biosciences (ANIX) Reports Positive Data in Ovarian Cancer CAR-T Trial - GuruFocus
Anixa Advances Ovarian Cancer CAR-T With Higher Dosing - TipRanks
Anixa Biosciences reports encouraging patient survival observations in ovarian cancer CAR-T trial - marketscreener.com
Anixa Biosciences Reports Encouraging Patient Survival Observations In Ovarian Cancer Car-T Trial - TradingView
ANIX: Major dose escalation approved after strong survival and safety data in ovarian cancer CAR-T trial - TradingView
Anixa Biosciences Reports Encouraging Data in Ovarian Cancer CAR-T Trial - TradingView
Anixa Biosciences Reports Encouraging Patient Survival Observations in Ovarian Cancer CAR-T Trial; Achieves Regulatory Approval Enabling Major Dose Escalation - PR Newswire
EXCLUSIVE: Anixa Biosciences' Ovarian Cancer Drug Candidate Shows Longer Survival With No Major Safety Issues - Benzinga
Here's Why We're Not Too Worried About Anixa Biosciences' (NASDAQ:ANIX) Cash Burn Situation - Yahoo Finance
ANIX: Analyst Maintains "Buy" Rating and $10 Price Target | ANIX Stock News - GuruFocus
D. Boral Capital Reiterates "Buy" Rating for Anixa Biosciences (NASDAQ:ANIX) - MarketBeat
Anixa Biosciences Secures United States Adopted Names Council Approval of Non-Proprietary Name for its CAR-T Therapy, a Key Step Toward Future Commercialization - BioSpace
Anixa Biosciences Secures United States Adopted Names Council Ap - GuruFocus
Anixa Biosciences (ANIX) CAR-T Therapy Receives USAN Approval - GuruFocus
Experimental ovarian cancer CAR-T earns official U.S. drug name - Stock Titan
Market Recap: Can Anixa Biosciences Inc keep up with sector leadersJuly 2025 Final Week & Daily Stock Trend Watchlist - baoquankhu1.vn
Anixa Biosciences Inc (NASDAQ:ANIX) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Insider Buying: Arnold Baskies Acquires Additional Shares of Ani - GuruFocus
Anixa Biosciences (NASDAQ:ANIX) Director Arnold Baskies Acquires 10,000 Shares - MarketBeat
Anixa Biosciences director Baskies buys $30,400 in stock By Investing.com - Investing.com UK
Anixa Biosciences director Baskies buys $30,400 in stock - Investing.com
Anixa Biosciences receives Mexican patent for breast cancer vaccine By Investing.com - Investing.com Australia
Institution Moves: Does Anixa Biosciences Inc have declining or rising EPSTrade Exit Report & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Anixa Biosciences Receives Notice of Allowance from Mexican Institute of Industrial Property (IMPI) for Patent Covering Breast Cancer Vaccine Technology - The AI Journal
Anixa Biosciences rises after Mexico approves patent for breast cancer vaccine - TradingView
Anixa Biosciences (ANIX) Secures Mexican Patent for Breast Cance - GuruFocus
Anixa Biosciences receives Mexican patent for breast cancer vaccine - Investing.com
Dividend Watch: Is Anixa Biosciences Inc gaining market shareMarket Performance Recap & Community Verified Trade Signals - baoquankhu1.vn
New Highs: Whats Anixa Biosciences Incs historical returnQuarterly Risk Review & Technical Analysis for Trade Confirmation - baoquankhu1.vn
ANIX: Initiating Coverage; Anixa's T-Cell Innovations Show Breakthrough Potential in Solid Tumors - Smartkarma
Anixa Biosciences Inc (NASDAQ:ANIX) Short Interest Update - Defense World
Can Anixa Biosciences Inc. maintain its current growth rateEarnings Trend Report & Accurate Technical Buy Alerts - bollywoodhelpline.com
AI Stocks: What hedge funds are buying NUWECPI Data & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Anixa Biosciences (NASDAQ:ANIX) Rating Increased to Hold at Wall Street Zen - MarketBeat
ANIX: D. Boral Capital Maintains Buy Rating with $10 Price Targe - GuruFocus
Anixa Biosciences (NASDAQ:ANIX) Issues Earnings Results, Meets Expectations - MarketBeat
Breakouts Watch: Will Anixa Biosciences Inc stock attract ESG investorsWeekly Stock Recap & Free Risk Controlled Daily Trade Plans - Bộ Nội Vụ
Anixa Biosciences : Annual Report for Fiscal Year Ending October 31, 2025 (Form 10-K) - marketscreener.com
Anixa Biosciences Inc SEC 10-K Report - TradingView — Track All Markets
Published on: 2026-01-11 17:33:32 - Улправда
ETF Watch: Will Anixa Biosciences Inc. stock deliver better than expected guidanceJuly 2025 Short Interest & Risk Adjusted Buy and Sell Alerts - Улправда
Why Anixa Biosciences Inc. stock appeals to dividend seekersWeekly Earnings Recap & Stock Timing and Entry Methods - Улправда
What catalysts could drive Anixa Biosciences Inc. stock higherWeekly Trade Recap & Verified Entry Point Detection - Улправда
Why analysts upgrade Anixa Biosciences Inc. stockStock Buyback Updates & Low Risk Trading Portfolio - Улправда
Anixa Biosciences Inc (NASDAQ:ANIX) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Anixa Biosciences (ANIX) Expected to Announce Quarterly Earnings on Friday - MarketBeat
0.47%
2.23%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):